Harvard researchers find that morning and afternoon physical activity significantly lowers the risk of developing type 2 diabetes, but evening activity shows no such benefit. The study also emphasizes that intensity matters more than consistency in reducing diabetes risk.
Iovance looks to advance its non-small cell lung cancer therapy – Pharmaceutical Technology
Lifileucel received a biologics license application (BLA) in May 2023, with a Prescription Drug User Fee Act (PDUFA) target action date set for 25 November
July 11, 2023